Japan Medical Dynamic Marketing, INC. Consolidated Provides Earnings Guidance for the Fiscal First Half of 2023 and Full Year Ending March 31, 2023
August 03, 2022 at 02:00 am EDT
Share
Japan Medical Dynamic Marketing, INC. provided consolidated earnings guidance for the fiscal first half of 2023 and full year ending March 31, 2023. For the first half, the company expects net sales to be JPY 10,200 million, operating profit to be JPY 1,100 million, net income attributable to owners of parent to be JPY 700 million or net income per share to be JPY 26.53.
For the year, the company expects net sales to be JPY 22,000 million, operating profit to be JPY 2,800 million, net income attributable to owners of parent to be JPY 1,850 million or net income per share to be JPY 70.12.
Japan Medical Dynamic Marketing, INC. is a Japan-based medical equipment provider. The Company is principally engaged in the import, development, manufacture and sale of medical equipment primarily in the field of orthopedic surgery. The Company has two segments. The Japan segment imports materials for osteosynthesis, artificial joints and spinal fixation devices from manufacturers, and sell them in Japan. The America segment is involved in the development and manufacture of materials for osteosynthesis, artificial joints, spinal fixation devices and other products, as well as the sale of medical equipment in North America. As of March 31, 2014, the Company had one subsidiary in the United States.
JAPAN MEDICAL DYNAMIC MARKETING, INC. 
